Juliana M. Bue‐Valleskey
Juliana M. Bue‐Valleskey publishes mostly in Endocrinology, Diabetes and Metabolism, Surgery and Genetics, on topics such as Diabetes Management and Research, Diabetes Treatment and Management and Diabetes, Cardiovascular Risks, and Lipoproteins.
- World rank
- #1,350,943 of 7,710,434 ranked researchers
- Rank in United States
- #428,138 of 1,627,098
- Works
- 42
- Citations
- 2.5k
- Citations per work
- 59.6
What does Juliana M. Bue‐Valleskey research?
Juliana M. Bue‐Valleskey's work is mostly in Medicine (82%), Biochemistry, Genetics and Molecular Biology (12%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3481.8%
- Medicine3481.8%
- Life Sciences511.8%
- Everything else36.4%
- 1Endocrinology, Diabetes and Metabolism68% of their works
- 2Surgery8% of their works
- 3Genetics7% of their works
- 4Molecular Biology4% of their works
- 5Physiology3% of their works
- 6Epidemiology3% of their works
Research topics
- Diabetes Management and Research
- Diabetes Treatment and Management
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes and associated disorders
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Pancreatic function and diabetes
- Metabolism, Diabetes, and Cancer
- Liver Disease Diagnosis and Treatment
Which keywords describe Juliana M. Bue‐Valleskey's research?
The keywords of their largest research topics: Glycemic Control, Insulin Therapy, Cardiovascular Disease, Diabetes, Type 1 Diabetes, Continuous Glucose Monitoring, Hypoglycemia and Cardiovascular Outcomes.
- NASH
- Metformin
- ß-Cell Dysfunction
- Hyperglycemia
- Critical Care
- Obesity
- Metabolic Syndrome
- Diabetes Mellitus
- Cardiovascular Outcomes
- Continuous Glucose Monitoring
- Diabetes
- Insulin Therapy
- Glycemic Control
- Cardiovascular Disease
- Type 1 Diabetes
- Hypoglycemia
- Type 2 Diabetes
- Insulin Resistance
- Glucose Metabolism
- Autoimmunity
- Genetics
- Pancreatic Islets
- AMP-Activated Protein Kinase
- NAFLD
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Glycemic Control643 topics
- Insulin Therapy643 topics
- Cardiovascular Disease412 topics
- Diabetes412 topics
- Type 1 Diabetes402 topics
- Continuous Glucose Monitoring321 topic
- Hypoglycemia321 topic
- Cardiovascular Outcomes241 topic
- Type 2 Diabetes241 topic
- Diabetes Mellitus162 topics
- Insulin Resistance122 topics
- Metabolic Syndrome122 topics
- Glucose Metabolism91 topic
- Obesity91 topic
- Autoimmunity81 topic
- Critical Care81 topic
- Genetics81 topic
- Hyperglycemia81 topic
- Pancreatic Islets81 topic
- ß-Cell Dysfunction81 topic
- AMP-Activated Protein Kinase51 topic
- Metformin51 topic
- NAFLD31 topic
- NASH31 topic
Where does Juliana M. Bue‐Valleskey work?
Juliana M. Bue‐Valleskey's main affiliation in the publication record is Eli Lilly (United States), United States.
How many publications and citations does Juliana M. Bue‐Valleskey have?
OpenAlex counts 42 works and 2,502 citations for Juliana M. Bue‐Valleskey, an h-index of 15, ranking #1,350,943 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Juliana M. Bue‐Valleskey. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.